PRIVISCL vs ROSSARI: Stock Comparison
PRIVI SPECIALITY CHE is the larger company by market capitalisation. PRIVI SPECIALITY CHE shows a higher ROE, a higher dividend yield and a higher ROCE, while ROSSARI BIOTECH shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
PRIVISCL leads 7; ROSSARI leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| Live Price | ₹3,556.1 | ₹446.15 |
| Day Change | 1.73% | -0.75% |
| Volume | 1.08 L | 36,449 |
| 52-Week High | ₹3,785.3 | ₹690.3 |
| 52-Week Low | ₹2,299.8 | ₹375 |
| Distance from 52W High | -6.06% | -35.37% |
Valuation
| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| Market Cap | ₹13,860 Cr | ₹2,491 Cr |
| P/E Ratio | 40x | 16.53x |
| P/B Ratio | 9.81x | 1.87x |
| EPS | ₹21.56 | ₹6.34 |
| Book Value | ₹368.79 | ₹240.71 |
| Dividend Yield | 0.28% | 0.11% |
Growth
| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.6% | 18.2% |
| EPS Growth (TTM YoY) | 40.9% | 33.5% |
| Qtr Sales Growth | 10.93% | 44.56% |
| Qtr Profit Growth | -1.69% | 2.42% |
Profitability & Leverage
| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| ROE | 24.86% | 11.19% |
| ROCE | 19.11% | 10.1% |
| Net Margin | 12.01% | 6.14% |
| Operating Margin | 22.23% | 9.56% |
| Debt to Equity | 0.5x | 0.31x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | PRIVISCL | ROSSARI |
|---|---|---|
| Promoter Holding | 60.6% | 63.63%▼ 0.01 pp |
| FII Holding | 1.94%▲ 0.56 pp | 2.02%▼ 0.16 pp |
| DII Holding | 10.08%▼ 0.59 pp | 14.64%▼ 3.56 pp |
| Public Holding | 27.38%▲ 0.02 pp | 15.2%▲ 3.74 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: PRIVI SPECIALITY CHE and ROSSARI BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.